1. Introduction {#s0005}
===============

Flavoproteins account for \~1% of proteins and are highly versatile enzymes, which perform many diverse reactions [@bib1], [@bib2]. In many cases a charge-transfer complex (CTC) is formed whose role remains elusive [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10]. In this way, we used type II NADH: quinone oxidoreductases (NDH-2s) to investigate how the flavin reactivity is controlled and modulated by the presence of the CTC.

NDH-2s are membrane proteins involved in respiratory chains and in the metabolic regeneration of NAD^+^. They are recognized as suitable targets for novel antimicrobial therapies considering they are the only enzymes with NADH:quinone oxidoreductase activity present in many pathogenic organisms, both bacteria and protozoa [@bib11]. These enzymes belong to the two-Dinucleotide Binding Domains Flavoprotein (tDBDF) superfamily, which share two structurally related Rossmann fold domains for the binding of dinucleotides (FAD and NADH) [@bib12]. Structural studies on NDH-2 have long contributed to the understanding of this enzyme, solving several controversies including the number and location of the substrate binding sites [@bib5], [@bib13], [@bib14], [@bib15]. Also the possible role of NDH-2 as a drug target as been thoroughly explored [@bib16], [@bib17], [@bib18]. Nevertheless, functional information is still not fully congruent and the reaction mechanism of NDH-2 remains unknown.

Previous pre-steady state kinetic studies of NDH-2 from *S. aureus*, reported the presence of a CTC formed between NAD^+^ and the reduced flavin, which is dissociated upon oxidation by the quinone (2,3-Dimethyl-1,4-naphthoquinone, DMN) [@bib5], indicating the involvement of a ternary complex in the catalytic mechanism of NDH-2. These studies also showed that FAD reduction by NADH was an order of magnitude faster than FADH~2~ oxidation by the quinone (180 ± 30 s^−1^ vs 5.0 ± 0.5 s^−1,^ respectively) and 2-n-Heptyl-4-hydroxyquinoline N-oxide (HQNO) inhibition only affected the kinetically limiting second half-reaction of the enzymatic turnover (0.08 ± 0.02 s). Intriguingly, NDH-2 from *Caldalkalibacillus thermarum* was also reported to establish a CTC upon reduction with NADH, but with similar FAD reduction and oxidation half-reaction rates (200 s^−1^) [@bib4]. In this case a different quinone analogue, menadione, was used, which has one less methyl group and a higher reduction potential then DMN (0 vs −90 mV) [@bib19], [@bib20], [@bib21].

Marreiros et al. [@bib22], recently proposed the first catalytic mechanism for NDH-2 family. In this study, which contemplates CTC formation coincidentally with NADH binding, aspartate 302 (D302), present in the vicinity of FAD, was observed to be totally conserved (100%), even among other members of the tDBDF superfamily. The authors suggested the involvement of D302 in the catalytic mechanism of NDH-2 as a putative proton donor in FAD reduction or proton acceptor in FADH~2~ oxidation. The authors have also observed the presence of a conserved glutamate residue (E172) in the proximity of the NADH binding site, and proposed it as part of a proton conductive pathway. This residue was later proved to be further involved in the stabilization of the NADH binding and CTC establishment [@bib23].

In the present work, we aimed at unraveling the role of the CTC in the reaction mechanism of NDH-2 and understanding its influence on flavin reactivity, in general.

2. Materials and methods {#s0010}
========================

2.1. Enzyme expression and purification {#s0015}
---------------------------------------

*E. coli* Rosetta 2 (DE3) pLysS cells were transformed with the plasmid pET-28a(+) (Novagen) carrying the gene SAOUHSC_00878, coding for NDH-2 from *S. aureus* NCTC8325. Protein expression and purification were conducted as described previously [@bib24]. Protein concentration was determined by the Pierce™ BCA protein assay kit or using the FAD extinction coefficient of 11.3 M^−1^ cm^−1^ [@bib25].

2.2. Kinetic studies {#s0020}
--------------------

Pre-steady state kinetic experiments were performed in a TgK Scientific stopped-flow instrument placed inside an anaerobic chamber and equipped with a diode array detector, capable of acquiring spectra in the wavelength range of 350--700 nm at a rate of 1 spectrum per 1.5 ms. The temperature of the drive syringes and mixing chamber was maintained at 15 °C and the pH was controlled with 100 mM potassium phosphate buffer pH 7.0, 250 mM NaCl. All solutions were prepared inside the anaerobic chamber with degassed water. The reductive reaction was monitored after mixing oxidized NDH-2 with NADH or sodium dithionite, Na~2~S~2~O~4~ (1:1 ratio). Reduced NDH-2 was mixed with quinone or O~2~ (1:2 ratio) to study the oxidative reaction. Complete turnovers were monitored using two equivalents of NADH/ sodium dithionite and quinone. Similar assays were performed in the presence of the inhibitor, HQNO.

2.3. Simulation of equilibrium protonation states {#s0025}
-------------------------------------------------

pH titration curves were calculated for all ionizable amino acid residues, including D302, of NDH-2 from *S. aureus* (PDB: 5NA1), based on the thermodynamics of proton binding as described before in detail [@bib26], [@bib27]. These methodologies use a combination of Poisson-Boltzmann (PB) calculations, performed with the program MEAD (version 2.2.9) [@bib28], [@bib29], [@bib30], and Metropolis Monte Carlo (MC) simulations, using the program PETIT (version 1.5) [@bib31]. Here, two systems were simulated: the fully reduced state FADH~2~ similar to that obtained with dithionite, and the fully reduced protein with NAD^+^ forming the charge transfer complex in the catalytic site, FADH~2~-NAD^+^. The position of the NAD^+^ was inferred upon fitting to the structure of the *S. cerevisiae* enzyme (PDB entry: 4G73).

3. Results and discussion {#s0030}
=========================

3.1. The presence of a Charge-transfer Complex {#s0035}
----------------------------------------------

In the oxidized form, NDH-2 presents an absorption spectrum with maxima at 375 and 450 nm and a shoulder close to 475 nm, typical of flavoproteins ([Fig. 1](#f0005){ref-type="fig"}). Upon reduction with NADH, the absorption at 375--450 nm decreases and a broad absorption band at the 650--800 nm region appears. This band is considered to be originated by the establishment of a CTC resulting from a π-π interaction between the parallel stacked isoalloxazine and nicotinamide rings of reduced FAD and NAD^+^ respectively. The enzyme was also reduced with sodium dithionite and in this case the decrease in absorption at 375--450 nm was also observed, but the band resulting from the establishment of the CTC was not detected ([Fig. 1](#f0005){ref-type="fig"}). A CTC could also be observed by adding NAD^+^ to the dithionite-reduced NDH-2 [@bib5], meaning that the CTC was formed only in the presence of the NAD^+^/FADH~2~, independently of the reducing agent.Fig. 1UV--visible absorption spectra of NDH-2 as purified (black solid line), reduced with NADH (blue solid line) or reduced with sodium dithionite (blue dashed line). The inserted figure expands absorption spectra in the 600--800 region (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).Fig. 1

3.2. The Charge-Transfer Complex is a limiting factor in protein oxidation {#s0040}
--------------------------------------------------------------------------

In order to investigate the role of the charge-transfer complex on the catalytic mechanism of NDH-2, we compared the oxidation of NDH-2 when reduced by NADH, which establishes a CTC, to that of the enzyme reduced by dithionite, which does not establish a CTC. Upon addition of quinone (in a 1:1 ratio) to NDH-2 previously reduced with NADH, spectral changes showed an increase in the absorbance peak at 450 nm and the disappearance of the broad band at 650--800 nm. The rate constant obtained for this second half-reaction was equal to 5.0 ± 0.5 s^−1^ ([Fig. 2](#f0010){ref-type="fig"}A) [@bib5]. The dithionite-reduced NDH-2 was mixed with DMN in a 1:1 ratio ([Fig. 2](#f0010){ref-type="fig"}B) and a rate constant equal to 196 ± 15 s^−1^ was measured. This reaction was approximately 40 times faster than the oxidation of the NADH-reduced NDH-2 ([Fig. 2](#f0010){ref-type="fig"}A) [@bib5] and interestingly similar to the rate constant for the reduction of the protein by NADH. In order to confirm whether the difference observed in the oxidation reaction of FAD was due to the presence of the CTC we incubated the dithionite-reduced enzyme with NAD^+^ and monitored its reaction with DMN (all the components were in a 1:1 ratio) ([Fig. 2](#f0010){ref-type="fig"}C). The rate constant obtained was 11.4 ± 2.2 s^−1^, which is comparable to that observed for the oxidation of the NADH-reduced enzyme by the quinone. These data indicate the presence of the CTC is a limiting factor in protein oxidation.Fig. 2Time-resolved oxidation by DMN of (A) NADH-reduced NDH-2 (1:1, protein:DMN ratio), (B) sodium dithionite-reduced NDH-2 (1:1, protein:DMN ratio) and (C) sodium dithionite-reduced NDH-2 in the presence of NAD^+^ (1:1:1, protein: DMN:NAD^+^ ratio), monitored at 450 nm (red dots) and at 670 nm (blue dots) (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).Fig. 2

3.3. The Charge-Transfer Complex decreases the oxidation rate independently of the oxidant {#s0045}
------------------------------------------------------------------------------------------

We also investigated whether the observed effect of the CTC on the oxidation reaction was dependent on the quinone, i.e., of the oxidant. For this we used oxygen, O~2~, as the electron acceptor. In the first experiment 10 µM NDH-2 was reduced with a stoichiometric amount of NADH and then the reduced NDH-2 was mixed with buffer containing 24 µM O~2~ in approximately 1:2 protein:O~2~ ratio ([Fig. 3](#f0015){ref-type="fig"}A).Fig. 3Time-resolved oxidation by O~2~ of (A) NADH-reduced NDH-2 (1:2, NDH-2: O~2~ ratio) and (B) dithionite-reduced NDH-2 (1:2, NDH-2: O~2~ ratio) monitored at 450 nm (red dots) and at 670 nm (blue dots) (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).Fig. 3

The oxidation of the protein by oxygen was very slow, with a rate constant of 0.0044 ± 0.0007 s^−1^. In this experiment we could also observe a decrease in absorbance at 650--800 nm due to the dissociation of the CTC ([Fig. 3](#f0015){ref-type="fig"}A). In a second experiment, we reduced the protein with sodium dithionite (1:1 ratio) and monitored its reaction with O~2~ (1:2 ratio). The rate constant obtained was 0.76 ± 0.2 s^−1^ higher than that measured for the oxidation of the NADH-reduced NDH-2. Also, as expected, the absorbance in the 650--800 nm region did not change, as a CTC was not present in the reduced enzyme to begin with. These results reinforce the idea that the presence of the CTC determines the oxidation rate of the protein.

3.4. The presence of the CTC determines the inhibitory effect of HQNO {#s0050}
---------------------------------------------------------------------

We previously showed that HQNO, a quinone derivative, acts as an inhibitor of *S. aureus´*NDH-2 activity with an apparent K~i~ value of 6.8 ± 0.4 µM. It was also demonstrated that the oxidation of the enzyme by DMN is strongly impaired in the presence of HQNO (unlike the first half reaction which is not affected) and that the binding sites for HQNO and the quinone are superimposed or very close [@bib5].

Here we tested whether the presence of the CTC, which also influences the second half reaction, would alter the effect of the inhibitor. For this we compared the effect of HQNO (10 µM) on the rate of protein oxidation by DMN (10 µM), in the case of NADH or dithionite reduced protein (10 µM). The rate of oxidation of dithionite-reduced protein by DMN in the presence of HQNO was 179 ± 12 s^−1^, a value similar to that obtained in the absence of the inhibitor, which suggests that in the absence of CTC the HQNO has no effect ([Fig. 4](#f0020){ref-type="fig"}B). This is completely different from the result obtained previously, where the oxidation of NDH-2 by DMN, after its reduction by NADH, was slowed-down by a factor of 50 (to 0.08 ± 0.02 s^−1^) in the presence of HQNO ([Fig. 4](#f0020){ref-type="fig"}A) [@bib5]. Again, in order to confirm whether the difference observed in the effect of HQNO was due to the presence of the CTC we incubated the dithionite-reduced enzyme with NAD^+^ and monitored its reaction with DMN in the presence of the inhibitor. In this situation we observed the protein oxidation was also very slow, with a rate constant of 0.1 ± 0.0006 s^−1^, a value that is similar to that obtained when the enzyme was reduced with NADH and then oxidized by DMN in the presence of HQNO ([Fig. 4](#f0020){ref-type="fig"}C).Fig. 4Time-resolved oxidation by DMN of (A) NADH- reduced NDH-2 in the presence of HQNO (1:1:5, NDH-2:DMN:HQNO ratio), (B) dithionite- reduced NDH-2 in the presence of HQNO (1:1:5, NDH-2:DMN:HQNO ratio) and (C) dithionite- reduced NDH-2 in the presence of HQNO and NAD^+^ (1:1:5:1, NDH-2:DMN:HQNO:NAD^+^ ratio).Fig. 4

3.5. The presence of the CTC influences the protonation probability of D302 {#s0055}
---------------------------------------------------------------------------

We performed protonation equilibrium simulations for all the ionizable amino acid residues of NDH-2 from *S. aureus.* Two different systems were simulated: the fully reduced state (FADH~2~), similar to that obtained with dithionite, and the fully reduced protein with NAD^+^ (FADH~2~-NAD^+^) in which the CTC is present.

Our protonation equilibrium simulations for NDH-2 from *S. aureus* indicate that the proton occupancy probability of the majority of the ionizable amino acid residues was not significantly altered by the presence of the CTC. D302 was the exception, for which our simulations clearly showed that its proton occupancy probability in the reduced enzyme is influenced by the presence of the CTC ([Fig. 5](#f0025){ref-type="fig"}).Fig. 5Proton equilibrium occupancy probability curves for D302 in two reduced conditions: FADH~2~ (in red) and FADH~2~-NAD^+^ (in green) (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).Fig. 5

According to the proposed catalytic mechanism of Marreiros et al. [@bib22], upon binding of NADH, FAD is reduced through hydride transfer to the N5 of the FAD isoalloxazine ring. The second proton needed for the full protonation of the reduced FAD is suggested to be provided by rearrangement of the hydrogen bond network around N1 in which a strictly conserved D302 is present. The high conservation of D302 is extended to several families of the tDBDF superfamily, further suggesting its importance in the oxidation/reduction processes of FAD. Upon quinone binding, FADH~2~ transfers two electrons to the quinone, which is provided of two protons by the previously observed putative proton pathways [@bib22]. After FADH~2~ oxidation, the flavin returns to its original conformation, leading to the release of the protons at N5 and N1. This proton at N1 undergoes the reverse process that restores the initial hydrogen bonding network around D302.

We observed that the proton occupancy probability curve of D302 in the case of FADH~2~ (in the absence of CTC) is different from that obtained in the case of FADH~2~-NAD^+^ (in the presence of the CTC). The curve in the presence of the CTC is shifted to higher pH values comparing to that obtained in its absence. This means that at pH 7 it is more difficult to oxidize FADH~2~-NAD^+^, because in this state D302 is almost 100% protonated and therefore unable to receive protons. In the absence of NAD^+^ at pH 7, D302 is expected to have a much lower proton occupancy, allowing proton transfer from the active site and faster oxidation of the FADH~2~.

Therefore, the difference observed for the proton occupancy probability of D302 of the reduced protein in the presence and absence of the CTC can contribute to explain the different oxidation rates observed by pre-steady state kinetics.

4. Conclusions {#s0060}
==============

The establishment of a CTC between flavoproteins and NADH is well documented, and has been observed for many enzymes catalyzing different reactions [@bib32]. Likewise, in previous work we described the formation of a CTC in the reduction of NDH-2 with NADH, which disappears upon oxidation by the quinone. In this work, we describe, for the first time, that the presence of the CTC controls the rate of the second half reaction and influences the effect of the inhibitor HQNO.

We show that the oxidation reaction is limited by the presence of the CTC because the dithionite-reduced NDH-2 oxidation rate is 40 times faster than the oxidation rate of the NADH-reduced NDH-2. The effect of the presence of the CTC is also observed when oxygen is the electron acceptor, revealing that the presence of the CTC decreases the rate of the second half reaction, independently of the oxidant. This set of results, summarized in [Table 1](#t0005){ref-type="table"}, can be partially explained by the protonation equilibrium simulations which revealed that the protonation of D302 in the reduced enzyme is strongly influenced by the presence of NAD^+^: protonated D302 populations at pH 7, which decreases from almost 100% in the presence of NAD^+^ to only 20% in its absence.Table 1Summary of kinetic rate constant values for the second half-reaction - flavin oxidation.Table 1**Oxidizing substrate / inhibitorReducing substrateDMNDMN+HQNOO**~**2**~**NADH**5.0 ± 0.50.08 ± 0.020.0044 ± 0.0007**Dith + NAD**^**+**^11.4 ± 2.20.1 ± 0.0006--**Dith**196 ± 15179 ± 120.76 ± 0.2

When testing HQNO, we noticed it decreases the rate of oxidation of the enzyme when the CTC is observed, having no effect when the enzyme is reduced with dithionite. In this case one could hypothesize that DMN could accept electrons from the unoccupied site of NADH. However we can rule out this hypothesis based on our previous data obtained by STD-NMR and Fluorescence spectroscopies, which showed that NADH and DMN interact with the protein at two different sites, without interfering with each other. We also observed that HQNO only affects the binding of DMN [@bib5] discarding the possibility of HQNO binding to the NADH site when the nucleotide is absent. Thus our present result indicates that the presence of the CTC produces conformational changes at the HQNO and quinone binding pocket(s), which may be favorable for the binding of HQNO and disadvantageous for the binding of the quinone. In this way, HQNO acted as a probe reflecting conformational changes at the quinone binding site. The hypothesis that the establishment of the CTC is disadvantageous for the binding of the quinone can also contribute to explain the observed difference in the rates of the second half reaction in the presence or absence of the CTC, in addition to its influence on the protonation probability of D302.

We can conclude that the presence of the CTC slows down the second half reaction. The physiological relevance of this effect is unknown, however we hypothesize it may contribute to keep a low quinol/quinone ratio and thus avoid the production of radical oxygen species by unspecific oxidation of quinol. We believe that our hypothesis for the physiological relevance of the molecular control of the enzymatic mechanism will foster further discussion and pave the way for *in vivo* studies.
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